Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP.

Por Katakami, Y, Nakao, Y, Koizumi, T, Katakami, N, Ogawa, R, Fujita, T
Publicado em 1988

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised,...

Por Saito, H., Yoshizawa, H., Yoshimori, K., Katakami, N., Katsumata, N., Kawahara, M., Eguchi, K.
Publicado em 2013

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

Por Negoro, S, Masuda, N, Takada, Y, Sugiura, T, Kudoh, S, Katakami, N, Ariyoshi, Y, Ohashi, Y, Niitani, H, Fukuoka, M
Publicado em 2003

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

Por Tanioka, M, Kitao, A, Matsumoto, K, Shibata, N, Yamaguchi, S, Fujiwara, K, Minami, H, Katakami, N, Morita, S, Negoro, S
Publicado em 2013

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.

Por Masuda, N., Fukuoka, M., Fujita, A., Kurita, Y., Tsuchiya, S., Nagao, K., Negoro, S., Nishikawa, H., Katakami, N., Nakagawa, K., Niitani, H.
Publicado em 1998

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group tri...

Por Kunitoh, H, Tamura, T, Shibata, T, Takeda, K, Katakami, N, Nakagawa, K, Yokoyama, A, Nishiwaki, Y, Noda, K, Watanabe, K, Saijo, N
Publicado em 2010

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Onco...

Por Tamura, K, Okamoto, I, Kashii, T, Negoro, S, Hirashima, T, Kudoh, S, Ichinose, Y, Ebi, N, Shibata, K, Nishimura, T, Katakami, N, Sawa, T, Shimizu, E, Fukuoka, J, Satoh, T, Fukuoka, M
Publicado em 2008

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

Por Yamamoto, N, Fukuoka, M, Negoro, S-I, Nakagawa, K, Saito, H, Matsui, K, Kawahara, M, Senba, H, Takada, Y, Kudoh, S, Nakano, T, Katakami, N, Sugiura, T, Hoso, T, Ariyoshi, Y
Publicado em 2004

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

Por Kubota, K., Sakai, H., Katakami, N., Nishio, M., Inoue, A., Okamoto, H., Isobe, H., Kunitoh, H., Takiguchi, Y., Kobayashi, K., Nakamura, Y., Ohmatsu, H., Sugawara, S., Minato, K., Fukuda, M., Yokoyama, A., Takeuchi, M., Michimae, H., Gemma, A., Kudoh, S.
Publicado no Ann Oncol (2015)